Wolfgang W. Wicha

580 total citations
24 papers, 408 citations indexed

About

Wolfgang W. Wicha is a scholar working on Small Animals, Pharmacology and Infectious Diseases. According to data from OpenAlex, Wolfgang W. Wicha has authored 24 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Small Animals, 15 papers in Pharmacology and 11 papers in Infectious Diseases. Recurrent topics in Wolfgang W. Wicha's work include Veterinary medicine and infectious diseases (23 papers), Pharmacological Effects of Natural Compounds (15 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Wolfgang W. Wicha is often cited by papers focused on Veterinary medicine and infectious diseases (23 papers), Pharmacological Effects of Natural Compounds (15 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Wolfgang W. Wicha collaborates with scholars based in United States, United Kingdom and Sweden. Wolfgang W. Wicha's co-authors include Steven P Gelone, Susanne Paukner, Anita Das, Leanne B. Gasink, Lisa Goldberg, Carolyn Sweeney, Christopher M. Rubino, Sujata M. Bhavnani, Dirk B Strickmann and William Prince and has published in prestigious journals such as JAMA, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Wolfgang W. Wicha

23 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wolfgang W. Wicha United States	9	245	193	115	100	85	24	408
Zrinka Ivezic‐Schoenfeld United States	9	238 1.0×	202 1.0×	69 0.6×	107 1.1×	82 1.0×	14	445
Aaron Walton Australia	10	164 0.7×	153 0.8×	295 2.6×	71 0.7×	5 0.1×	19	395
Sarah Whalley United Kingdom	13	30 0.1×	234 1.2×	295 2.6×	123 1.2×	11 0.1×	16	507
Anette Veringa Netherlands	13	36 0.1×	428 2.2×	287 2.5×	23 0.2×	22 0.3×	17	560
Kim Credito United States	16	45 0.2×	410 2.1×	318 2.8×	255 2.5×	30 0.4×	27	776
Gennethel Pennick United States	11	60 0.2×	659 3.4×	481 4.2×	15 0.1×	14 0.2×	16	735
Michal Kantecki France	12	64 0.3×	503 2.6×	369 3.2×	53 0.5×	7 0.1×	28	645
Dena M. Hensey United States	9	42 0.2×	126 0.7×	239 2.1×	141 1.4×	16 0.2×	9	574
S. Ken Tanaka United States	9	60 0.2×	90 0.5×	117 1.0×	62 0.6×	11 0.1×	11	359
Daniel K. Reynolds United States	9	33 0.1×	198 1.0×	160 1.4×	34 0.3×	8 0.1×	10	349

Countries citing papers authored by Wolfgang W. Wicha

Since Specialization

Citations

This map shows the geographic impact of Wolfgang W. Wicha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang W. Wicha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang W. Wicha more than expected).

Fields of papers citing papers by Wolfgang W. Wicha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang W. Wicha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang W. Wicha. The network helps show where Wolfgang W. Wicha may publish in the future.

Co-authorship network of co-authors of Wolfgang W. Wicha

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang W. Wicha. A scholar is included among the top collaborators of Wolfgang W. Wicha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang W. Wicha. Wolfgang W. Wicha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paukner, Susanne, et al.. (2024). In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice. International Journal of Molecular Sciences. 25(10). 5401–5401. 2 indexed citations

Ke, Alice, et al.. (2024). Physiologically‐based pharmacokinetic modeling of the drug–drug interaction between ivacaftor and lefamulin in cystic fibrosis patients. CPT Pharmacometrics & Systems Pharmacology. 13(4). 589–598. 1 indexed citations

Sawicki, Gregory S., et al.. (2024). Safety and Pharmacokinetics Following Oral or Intravenous Lefamulin in Adults With Cystic Fibrosis. Clinical Therapeutics. 46(2). 96–103. 2 indexed citations

Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2022). Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections. Frontiers in Pharmacology. 13. 1035841–1035841. 21 indexed citations

Wicha, Wolfgang W., et al.. (2022). Tissue Distribution of [ ¹⁴ C]-Lefamulin into the Urogenital Tract in Rats. Antimicrobial Agents and Chemotherapy. 66(8). e0035522–e0035522. 3 indexed citations

Häfner, Michael, et al.. (2021). Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse model. PLoS ONE. 16(9). e0237659–e0237659. 6 indexed citations

Wicha, Wolfgang W., Thomas Marbury, James A. Dowell, et al.. (2021). Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired‐hepatic function. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(5). 457–462. 8 indexed citations

Wicha, Wolfgang W., Thomas Marbury, James A. Dowell, et al.. (2021). Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(5). 451–456. 7 indexed citations

Wicha, Wolfgang W., et al.. (2019). Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing. Journal of Antimicrobial Chemotherapy. 74(Supplement_3). iii19–iii26. 25 indexed citations

10.

Zhang, Li, Wolfgang W. Wicha, Sujata M. Bhavnani, & Christopher M. Rubino. (2019). Prediction of lefamulin epithelial lining fluid penetration after intravenous and oral administration using Phase 1 data and population pharmacokinetics methods. Journal of Antimicrobial Chemotherapy. 74(Supplement_3). iii27–iii34. 18 indexed citations

11.

Wicha, Wolfgang W., Thomas Marbury, James A. Dowell, et al.. (2019). 705. Pharmacokinetics (PK) and Safety of Lefamulin (LEF) After Single Intravenous Dose Administration in Subjects With Impaired Renal Function and in Those Requiring Hemodialysis. Open Forum Infectious Diseases. 6(Supplement_2). S318–S318. 2 indexed citations

12.

Wicha, Wolfgang W., Dirk B Strickmann, & Susanne Paukner. (2019). Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model withStaphylococcus aureusandStreptococcus pneumoniae. Journal of Antimicrobial Chemotherapy. 74(Supplement_3). iii11–iii18. 33 indexed citations

13.

Alexander, Elizabeth, Lisa Goldberg, Anita Das, et al.. (2019). Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia. JAMA. 322(17). 1661–1661. 82 indexed citations

14.

Bhavnani, Sujata M., Li Zhang, Jeffrey Hammel, et al.. (2019). Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia. Journal of Antimicrobial Chemotherapy. 74(Supplement_3). iii35–iii41. 23 indexed citations

15.

Wicha, Wolfgang W., Thomas Marbury, James A. Dowell, et al.. (2019). 722. Pharmacokinetics (PK) and Safety of Lefamulin (LEF) After Single Intravenous Dose Administration in Subjects With Impaired Hepatic Function. Open Forum Infectious Diseases. 6(Supplement_2). S324–S325. 1 indexed citations

16.

Kappes, Barbara, et al.. (2017). Efficacy of Lefamulin Against Staphylococcus aureus-Induced Bacteremia in a Neutropenic and Immunocompetent Murine Model. Open Forum Infectious Diseases. 4(suppl_1). S471–S471. 4 indexed citations

17.

Bhavnani, Sujata M., Li Zhang, Christopher M. Rubino, et al.. (2016). Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Oral Lefamulin Dose Selection in the Treatment of Patients with Community-Acquired Bacterial Pneumonia (CABP). Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

18.

Zhang, Li, et al.. (2016). Population Pharmacokinetic (PPK) Analysis for Lefamulin Using Phase 1 Data and Assessment of Optimal PK Sampling Strategies (OSS) for a Phase 3 Community-Acquired Bacterial Pneumonia (CABP) Study. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

19.

Bhavnani, Sujata M., Paul G. Ambrose, Wolfgang W. Wicha, et al.. (2015). Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment (TA) Analyses Supporting Lefamulin Dose Selection for the Treatment of Patients With Community-Acquired Bacterial Pneumonia (CABP). Open Forum Infectious Diseases. 2(suppl_1). 3 indexed citations

20.

Rubino, Christopher M., Xue Bai, Sujata M. Bhavnani, et al.. (2014). Population Pharmacokinetic Analyses for BC-3781 Using Phase 2 Data from Patients with Acute Bacterial Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 59(1). 282–288. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact